Delivery Order SPE2DB25D3005-SPE2DB25FQDMK
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,325.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of January 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is the prime contractor and holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,475.52 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.95 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $43,449.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides the DLA with Firm Fixed Price delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a period of performance through January 23, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $8,139.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, which is a respiratory medication. This contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of January 10, 2025. The contract is not designated as a set-aside....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a medical product. The $1,580.79 firm fixed-price delivery order contract has an ultimate completion date of January 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $4,571.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg inhalers, a pharmaceutical product used in the treatment of respiratory conditions. The contract has a completion date of June 21, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award, valued at $1,598.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 1, 2024. This delivery order contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,315.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. This award is not associated with any set-aside designation, indicating open competition. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of...